Absence of hypercoagulability after nCoV-19 vaccination: An observational pilot study
nCoV-19 백신 접종 후 과응고의 부재: 관찰 파일럿 연구
Observational Study
[키워드] activating
Activation
ADP
age
aggregation
BNT162b2
BNT162b2 vaccine
BNT162b2 vaccines
Care
carriers
ChAdOx1
ChAdOx1 vaccine
ChAdOx1 vaccines
clinically
Coagulation
Cohort
comparable
control group
controls
COVID-19
COVID-19 vaccine
COVID-19 vaccines
eligible
endogenous
evaluated
fibrinogen
first dose
Gender
groups
Health
Health care
healthy subject
healthy subjects
hypercoagulability
hypercoagulable
induce
no difference
no differences
oral contraceptive
oral contraceptives
parameter
peptide
pilot study
plasma
Platelet
platelet aggregation
Platelet count
predisposition
professional
prothrombotic state
receptor
SARS-CoV-2
subject
thrombin
Thrombin generation
thrombin receptor
Thrombophilia
thrombosis
TRAP
university
vaccination
Vaccine
Volunteer
Whole blood
women
[DOI] 10.1016/j.thromres.2021.06.016 PMC 바로가기 [Article Type] Observational Study
[DOI] 10.1016/j.thromres.2021.06.016 PMC 바로가기 [Article Type] Observational Study